vTv Therapeutics (VTVT) Total Current Liabilities (2014 - 2026)

vTv Therapeutics (VTVT) has 13 years of Total Current Liabilities data on file, last reported at $6.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 59.43% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (up 59.43% YoY), and the FY2025 full-year result was $6.6 million, up 27.81% from the prior year.
• Total Current Liabilities advanced to $6.9 million in Q1 2026, from $6.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $12.7 million in Q1 2022 to a low of $4.3 million in Q1 2025.
• A 5-year average of $8.1 million and a median of $7.7 million in 2022 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities soared 146.03% in 2022 and sank 51.62% in 2025, its largest moves.
• Tracing VTVT's Total Current Liabilities over 5 years: stood at $7.7 million in 2022, then soared by 37.77% to $10.6 million in 2023, then sank by 51.07% to $5.2 million in 2024, then rose by 27.81% to $6.6 million in 2025, then increased by 3.61% to $6.9 million in 2026.
• Business Quant data shows VTVT's Total Current Liabilities at $6.9 million in Q1 2026, $6.6 million in Q4 2025, and $10.2 million in Q3 2025.